Astera Labs, Inc. $ALAB Shares Purchased by Royal London Asset Management Ltd.

Key Points

• Royal London Asset Management increased its Astera Labs stake by 8.7% in the second quarter, bringing its holdings to 45,588 shares worth approximately $22.0 million. Institutional investors collectively own 60.47% of ALAB.
• Astera Labs reported stronger-than-expected quarterly results, with EPS of $0.80 versus $0.69 expected and revenue of $392.4 million, up 104.5% year over year. The company issued third-quarter 2026 EPS guidance of $1.16–$1.21.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and a $340.53 target price, although insiders have sold 419,244 shares worth $163.1 million over the past 90 days.

Royal London Asset Management Ltd. boosted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 8.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 45,588 shares of the company's stock after purchasing an additional 3,659 shares during the period. Royal London Asset Management Ltd.'s holdings in Astera Labs were worth $22,020,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in ALAB. Royal Bank of Canada lifted its position in shares of Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company's stock valued at $9,097,000 after acquiring an additional 95,409 shares during the last quarter. AQR Capital Management LLC increased its stake in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company's stock worth $680,000 after purchasing an additional 7,756 shares in the last quarter. Empowered Funds LLC raised its holdings in Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company's stock worth $277,000 after buying an additional 4,183 shares during the period. First Trust Advisors LP raised its holdings in Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company's stock worth $10,196,000 after buying an additional 56,952 shares during the period. Finally, Brown Advisory Inc. lifted its stake in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company's stock valued at $505,000 after buying an additional 1,977 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Stock Performance

Astera Labs stock opened at $289.47 on Monday. The firm has a market cap of $50.22 billion, a PE ratio of 143.30 and a beta of 3.84. The firm's 50 day moving average price is $342.38 and its two-hundred day moving average price is $250.08. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter last year, the business posted $0.44 EPS. The company's revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have commented on ALAB shares. Roth Capital reiterated a "buy" rating and issued a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Evercore restated an "outperform" rating and issued a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. UBS Group reiterated a "neutral" rating and set a $425.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Needham & Company LLC raised their target price on Astera Labs from $260.00 to $425.00 and gave the stock a "buy" rating in a research report on Wednesday, August 5th. Finally, Zacks Research upgraded Astera Labs from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $340.53.

Insider Transactions at Astera Labs

In other news, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. The trade was a 11.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the business's stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares of the company's stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 419,244 shares of company stock valued at $163,135,169. Corporate insiders own 10.40% of the company's stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source